The influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification the IRIVASC-trial
29 August 2022 (12:15 - 13:00)
Organised by:
Abstract
Slides
About the speaker
University Hospital Frankfurt, Frankfurt (Germany)
6 More presentations in this session
Doctor B. Alos (Poitiers, FR)
Doctor J. Viegas (Lisbon, PT)
Doctor D. Laohachewin (Bad Krozingen, DE)
Access the full session
The Event
ESC Congress 2022
29 August 2022
12:15 CET
You may be interested in
Congress Presentation
